Summary:Diarrhea is a difficult diagnostic problem in patients with chronic graft-versus-host disease (cGVHD) because there are many causes of it. Although intestinal involvement has been reported in early studies of untreated cGVHD, this is now a very rare presentation of the disease. In addition to other etiologies, pancreatic insufficiency should also be considered in patients with cGVHD who demonstrate malabsorption. The pathogenesis of pancreatic insufficiency in these patients is unknown. Pancreatic enzyme supplements can be very effective in treating this rare condition. Bone Marrow Transplantation (2001) 27, 163-166. Keywords: chronic GVHD; malabsorption; diarrhea; pancreas; pancreatic insufficiency Although the incidence of diarrhea falls after day 100 following hematopoietic stem cell transplantation, it can still be a problem, particularly in patients with ongoing graftversus-host disease (GVHD). 1,2 The most common cause of diarrhea in long-term transplant survivors is infection because of the incomplete immune reconstitution in the majority of these patients, especially in those with cGVHD. [2][3][4][5][6] Although intestinal involvement in patients with untreated cGVHD was described in early studies, this is now a very rare phenomenon because of the widespread use of potent immunosuppressive(s) in the treatment of extensive cGVHD. The lower gastrointestinal (GI) tract, particularly the small bowel, is less frequently affected by cGVHD than the esophagus. The diagnosis of GI involvement by cGVHD requires extensive evaluation to rule out other causes of malabsorption or maldigestion. 5,6 In this report, we present four cases with unexplained diarrhea masquerading as chronic gut GVHD.
Case reports
Case oneA 38-year-old white male with chronic myelogeneous leukemia in chronic phase underwent allogeneic bone marrow transplantation (BMT) from his HLA-identical sibling following a busulfan/cyclophosphamide conditioning regimen. His past history was significant for abdominal trauma due to a motor vehicle accident. Approximately 3 months after his BMT, the patient developed a skin rash, oral lichenoid changes and dry eye symptoms, which were consistent with chronic GVHD. A skin biopsy was inconclusive but a salivary gland biopsy confirmed the diagnosis of cGVHD. He responded to an immunosuppressive regimen which included steroids, cyclosporine and PUVA.At the 6 month follow-up visit, he was noted to have abdominal discomfort, bloating and nausea, which did not improve with an H-2 receptor blocker, omeprazole, propulsid or ondansetron. An esophagogastroduedenoscopy (EGD) was unremarkable. Gastric and duodenal biopsies were negative for GVHD and any infectious agents. Subsequently, his cGVHD flared with increased oral symptoms associated with lichenoid lesions, skin rash and abnormal liver function tests. Thalidomide was added to cyclosporine and prednisone. Although his cGVHD improved with this therapy, the GI symptoms persisted. At 20 months post BMT, he developed upper abdominal pain and diarrhea. His dia...